HBAN
Huntington Bancshares Incorporated
HBAN offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
JPM
JPMorgan Chase & Co.
JPM has a slight edge over HBAN overall, supported by stronger fundamentals and lower modeled downside.
HBAN Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| N/A | |
| N/A |
HBAN's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like HBAN.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
HBAN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.3x | $11.20 | -29% |
| Forward | 9.5x | $15.73 | — |
| Fair | 12x | $14.97 | -4.9% |
| Current | 13x | $15.73 | — |
| Expensive | 17x | $19.98 | +27% |
Historical ranges are pointers, not guarantees.
HBAN's PE is in its fair range at 13x. If earnings grow as analysts expect, today's price would be 9.5x next year's earnings, in its cheap range.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over HBAN in the historical PE scenario, which offers more potential upside but is not a forecast.
HBAN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
HBAN has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
HBAN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.66 | +38% |
| Q3 2026 | $1.21 | -15% |
| Q2 2026 | $1.29 | -3.7% |
| Q1 2026 | $1.30 | 0% |
| Q4 2025 | $1.39 | +14% |
| Q3 2025 | $1.42 | +37% |
| Q2 2025 | $1.34 | +26% |
| Q1 2025 | $1.30 | +17% |
| Q4 2024 | $1.22 | -1.6% |
HBAN earned $1.21 per share over the past year, down 15% from the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over HBAN on earnings, with more consistent year-over-year improvement.
HBAN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.8B | +31% |
| Q2 2026 | $2.8B | +46% |
| Q1 2026 | $2.6B | +34% |
| Q4 2025 | $2.2B | +11% |
| Q3 2025 | $2.1B | +14% |
| Q2 2025 | $1.9B | +7.5% |
| Q1 2025 | $1.9B | +9.5% |
| Q4 2024 | $2B | +14% |
HBAN has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -3.8 points |
| Q2 2026 | 32% | -1.3 points |
| Q1 2026 | 25% | -9.1 points |
| Q4 2025 | 29% | -5.2 points |
| Q3 2025 | 36% | +1.9 points |
| Q2 2025 | 33% | +0.4 points |
| Q1 2025 | 34% | +4.9 points |
| Q4 2024 | 34% | +20 points |
HBAN's operating margin was 32% last quarter, down 3.8 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over HBAN on profitability, with a higher operating margin.
HBAN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $683M | +53% |
| Q2 2026 | $1B | +105% |
| Q1 2026 | $400M | -13% |
| Q4 2025 | $810M | -44% |
| Q3 2025 | $446M | +$926M |
| Q2 2025 | $500M | +90% |
| Q1 2025 | $459M | +6.3% |
| Q4 2024 | $1.5B | +74% |
HBAN has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
HBAN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -1.4M shares |
| 1 year | +38% | +566M shares |
| 3 years | +40% | +581M shares |
| 5 years | +82% | +922M shares |
| Available history | +94% | +991M shares |
HBAN has 2B diluted shares, up 38% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $100M |
| Q2 2026 | $159M |
| Q1 2026 | $150M |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | $150M |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over HBAN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
HBAN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.5x | High |
| Q2 2026 | 5.0x | High |
| Q1 2026 | 6.3x | High |
| Q4 2025 | 4.8x | High |
| Q3 2025 | 4.6x | High |
| Q2 2025 | 5.0x | High |
| Q1 2025 | 5.4x | High |
| Q4 2024 | 4.9x | High |
HBAN's net debt is about 5.5 years of its operating earnings (EBITDA), up from 4.6 years a year ago. Net leverage isn't a meaningful measure for financial services companies like HBAN.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over HBAN on leverage, with a lower net debt burden relative to earnings.
HBAN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.8 | Neutral |
| Stochastic | 25.1 | Neutral |
HBAN's weekly RSI is 44 (neutral) and its Stochastic is 25 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
HBAN PE vs Financial Services Sector
| Metric | HBAN | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.2% below |
| PE % | 62 | 63 | 1 pt below |
HBAN has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
HBAN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.5 | 1.3% above |
| 20 week MA | $16.6 | 5.2% below |
| 50 week MA | $16.8 | 6.1% below |
| 100 week MA | $16.4 | 4.2% below |
| 200 week MA | $14.7 | 7.2% above |
HBAN's trend is mixed: it's above two of its five weekly moving averages, and 7.2% above its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over HBAN on trend strength, trading above more of its moving averages.
HBAN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.1 | $12.4 | -18% |
| 2021 | $12.4 | $15.3 | +24% |
| 2022 | $15.3 | $14.1 | -7.9% |
| 2023 | $14.1 | $12.7 | -9.5% |
| 2024 | $12.7 | $16.4 | +29% |
| 2025 | $16.4 | $17.7 | +8.3% |
| 2026 YTD | $17.7 | $15.7 | -11% |
HBAN has finished lower in three of the last six years. It's down 11% so far in 2026.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over HBAN on returns for 2026, with the stronger performance.